医学
重症监护室
败血症
危险系数
尿
比例危险模型
内科学
接收机工作特性
脂质运载蛋白
沙发评分
混淆
胃肠病学
曲线下面积
前瞻性队列研究
置信区间
作者
Rui Zhao,Jianghua Liu,Zeliang Qiu
出处
期刊:Clinical and Investigative Medicine
日期:2024-03-01
卷期号:47 (1): 4-12
被引量:1
标识
DOI:10.3138/cim-2024-2672
摘要
Introduction We aimed to investigate the association of iron metabolism-related parameters with 60-day mortality in critically ill patients with sepsis. Methods Serum or urine concentrations of iron metabolism-related parameters on intensive care unit admission were measured in a prospective cohort of 133 eligible patients with sepsis according to the Sepsis-3 criteria, and these values were compared between survivors and nonsurvivors, categorized according to their 60-day survival status. Cox regression analyses were performed to examine the association between iron parameters and 60-day mortality. Kaplan-Meier methods were used to illustrate the differences in survival between different iron parameters. Results Of the 133 patients included in the study, 61 (45.8%) had died by day 60. After adjusting for confounding variables, higher concentrations of serum iron (cut-off 9.5 μmol/mL) and higher concentrations of urine neutrophil gelatinase-associated lipocalin (uNGAL; cut-off 169.3 ng/mL) were associated with a significantly greater risk of death in the Cox regression analysis. These two biomarkers combined with Sequential Organ Failure Assessment (SOFA) scores increased the area under the receiver operating characteristic (AUROC) curve to 0.85. Discussion These findings suggest that higher concentrations of serum iron and uNGAL are each associated with higher 60-day mortality, and they add significant accuracy to this prediction in combination with SOFA. Abbreviations: uNGAL: urine neutrophil gelatinase-associated lipocalin; ICU: intensive care unit; SOFA: Sequential Organ Failure Assessment; APACHE II: the Acute Physiology and Chronic Health Evaluation II; ELISA: enzyme-linked immunosorbent assay; HR: hazard ratio; CIs: confidence intervals; WBC: white blood cell; TBIL: total bilirubin
科研通智能强力驱动
Strongly Powered by AbleSci AI